LINDSEY BEST: Open Payments
NPI 1255199600 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,734 in 147 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,499 · 2025 $3,734
Food & beverage: $3,556Education: $177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $857 |
| GlaxoSmithKline, LLC. | 29 | $474 |
| United Therapeutics Corporation | 6 | $317 |
| Verona Pharma, Inc. | 15 | $256 |
| Actelion Pharmaceuticals US, Inc. | 16 | $224 |
| Regeneron Healthcare Solutions, Inc. | 5 | $199 |
| Inari Medical, Inc. | 1 | $194 |
| Insmed, Inc. | 8 | $186 |
| Merck Sharp & Dohme LLC | 6 | $141 |
| ANI Pharmaceuticals, Inc. | 4 | $121 |
Products named: AIRSUPRA, NUCALA, FASENRA, Ohtuvayre, DUPIXENT, FLOWTRIEVER CATHETER, S, Arikayce, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
